Aurobindo Pharma reported INR9.03B in Net Income for its fiscal quarter ending in March of 2025.


Net Income Change Date
Cipla INR 12.98B 757.8M Jun/2025
Divis Laboratories Ltd 5.45B 1.17B Jun/2025
Dr.Reddys Laboratories INR 14.18B 1.69B Jun/2025
Hindustan Unilever INR 27.56B 2.92B Jun/2025
Sun Pharmaceuticals INR 22.79B 1.29B Jun/2025
UPL INR -880000000 9.84B Jun/2025